MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accrued expenses and other curre...
Stock-based compensation expense
Proceeds from stock option exerc...
Others
Negative Cash Flow Breakdown
Change in fair value of warrant ...
Accounts payable
Other assets
Operating lease liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-8,328
-12,415
4,612
-16,407
Depreciation expense
20
46
47
427
Non-cash operating lease expense
-
-
173
117
Stock-based compensation expense
1,587
1,582
1,838
1,940
Change in fair value of warrant liability
-4,119
581
-15,758
-3,872
Impairment of long-lived assets
-
-
0
2,205
Gain on sale of property and equipment
0
510
-
-
Prepaid expenses and other current assets
-21
-982
-560
-5,641
Other non-current assets
-
-
-619
-
Other assets
1,017
-
-
-4
Accounts payable
-1,307
1,380
-3,169
-1,828
Accrued expenses and other current liabilities
2,858
-2,965
-1,963
400
Operating lease liabilities
-362
-350
-282
-177
Net cash used in operating activities
-10,028
-11,669
-13,942
-11,550
Purchase of property and equipment
-
-
-
0
Proceeds from sale of property and equipment
0
550
-
-
Net cash provided by investing activities
0
550
-
0
Proceeds from issuance of common stock under at the market equity offering program, net of offering costs
-
-
-124
0
Proceeds from issuance of common stock, common warrants and pre-funded warrants from public offerings
-
-
-
2,596
Payments of financing costs
-
-
-
628
Proceeds from issuance of common stock, common warrants and pre-funded warrants, net of offering costs
-
-
62,837
-
Proceeds from stock option exercise and purchases under the employee stock purchase plan
159
-
42
0
Net cash provided by financing activities
159
-
23,112
1,968
Net decrease in cash, cash equivalents, and restricted cash
-9,869
-11,119
9,170
-9,582
Cash, cash equivalents, and restricted cash at the beginning of the period
45,062
56,181
47,011
58,648
Cash, cash equivalents, and restricted cash at the end of the period
35,193
-
-
-
Cash and cash equivalents
34,824
-
-
-
Restricted cash
369
-
-
-
Cash, cash equivalents, and restricted cash at the end of the period
35,193
45,062
56,181
47,011
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from stock
option exercise and...
$159K
(35.90%↑ Y/Y)
Net cash provided by
financing activities
$159K
(-99.63%↓ Y/Y)
Net decrease in
cash, cash...
-$9,869K
(-380.24%↓ Y/Y)
Canceled cashflow
$159K
Accrued expenses and
other current...
$2,858K
(118.50%↑ Y/Y)
Stock-based compensation
expense
$1,587K
(-72.36%↓ Y/Y)
something is missing
$619K
Prepaid expenses and
other current assets
-$21K
(98.70%↑ Y/Y)
Depreciation expense
$20K
(-97.86%↓ Y/Y)
Net cash used in
operating activities
-$10,028K
(77.66%↑ Y/Y)
Canceled cashflow
$5,105K
Net loss
-$8,328K
(83.34%↑ Y/Y)
Change in fair value of
warrant liability
-$4,119K
(-1714.54%↓ Y/Y)
Accounts payable
-$1,307K
(72.21%↑ Y/Y)
Other assets
$1,017K
(265.37%↑ Y/Y)
Operating lease
liabilities
-$362K
(78.93%↑ Y/Y)
Buy us a coffee
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. (BMEA)